Latin America and the Caribbean vs North Macedonia: Percentage of bloodstream infection due to methicillin-resistant

Latin America and the Caribbean
39.0%
in 2022
North Macedonia
53.8%
in 2022
Latin America and the Caribbean rank
10th
North Macedonia rank
9th

Percentage of bloodstream infection due to methicillin-resistant over time

  • Latin America and the Caribbean
  • North Macedonia
406080100201620192022

How they compare

North Macedonia currently reports 53.8% against 39.0% in Latin America and the Caribbean, a difference of 14.8%.

That makes North Macedonia's figure about 1.4 times Latin America and the Caribbean's.

Across all 6 years both countries report, North Macedonia has been ahead every year.

Latin America and the Caribbean ranks 10th and North Macedonia ranks 9th of 15 groups.

North Macedonia has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Latin America and the Caribbean North Macedonia Difference Ahead
2010s 39.2% 51.0% 11.7% North Macedonia
2020s 40.5% 78.2% 37.7% North Macedonia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher percentage of bloodstream infection due to methicillin-resistant, Latin America and the Caribbean or North Macedonia?
North Macedonia, at 53.8% against 39.0% in Latin America and the Caribbean as of 2022.
What is the difference in percentage of bloodstream infection due to methicillin-resistant between Latin America and the Caribbean and North Macedonia?
14.8%, with North Macedonia ahead.
How many years of comparable data are there for Latin America and the Caribbean and North Macedonia?
6 years are reported by both, from 2017 to 2022.
How do Latin America and the Caribbean and North Macedonia rank globally for percentage of bloodstream infection due to methicillin-resistant?
Latin America and the Caribbean ranks 10th and North Macedonia ranks 9th of 15 groups.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Latin America and the Caribbean vs North Macedonia: Percentage of bloodstream infection due to methicillin-resistant. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 15 September 2026, from https://development-goals.statizoid.com/compare/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/latin-america-and-the-caribbean/north-macedonia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/latin-america-and-the-caribbean/north-macedonia/">Latin America and the Caribbean vs North Macedonia: Percentage of bloodstream infection due to methicillin-resistant</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
65 places, 396 data points, 2016–2022
Last refreshed